Orthobiologics Market: Viscosupplements Product Type Segment to Gain Traction by the End of the Forecast Period: Global Industry Analysis (2012 - 2016) and Opportunity Assessment (2017 - 2027)
Weighted analysis to achieve strategic proficiency
The market research study on orthobiologics market drafted by Future Market Insights is an extensive research publication that covers the global scenario of orthobiologics market. It includes various macroeconomic factors, opportunity assessment, key growth drivers, restraints and vital segmental analysis. The quantification of data pertaining to these aspects with the help of statistical representations and analysis giving a holistic and an unbiased view of the entire market. The research publication assists the reader in judging the future prospects in orthobiologics across key regions in the globe. Every market segment is assessed in different regions giving a heads up to the reader and assisting in determining revenue pockets for the growth of his/her business. The statistical analysis and forecasting helps in getting a clear market understanding and its scenario in the future based on market acumen of current market standing and historical data. Data mining and number crunching is done with extreme precision to cover analysis of the entire ecosystem of the orthobiologics market. All these insights and qualitative and quantitative analysis of the market is presented in a systematic format in the research report titled “Orthobiologics Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)”.
Assumptions used in this research report
While drafting this extensive research report, we have considered market consolidation activities such as merger and acquisition, collaborations, partnerships, which may influence the market growth over a forecast period. Capital expenditure on healthcare infrastructure in the developing economies is also a factor, expected to drives the market. It also rules out impact of extreme events in specific countries. Regulatory impositions such as the rules and regulations by the various regulatory authorities such as U.S. Food and Drug Administration and European Commission could affect the market. Currency fluctuations and changing taxation policies would have a significant impact on forecasting of orthobiologics over the forecast period.
Reasons supporting your investment in this research report
This research study gives a near to 100 percent accurate results pertaining to every segment globally as well as regionally, during the current year as well as 10 years down the line (2017-2027). To ensure data and statistical accuracy, an effective research methodology has been followed that covers extensive secondary research to acquire relevant market details such as overall market size, top players in the industry, top products, important regions, new developments etc., which is validated using primary research to remove deviations and arrive at a data with high precision. This is done by interviewing many industry specialists and subject matter experts, and also the data extracted from company websites, white papers, financial reports etc. All the information gathered is then integrated by Future Market Insights analysts to arrive at final data points pertaining to the global orthobiologics market. The market statistics are presented in a systematic and organised manner with diagrams, graphs etc., which helps the readers grasp the key outcomes at just a single glance. Moreover, a 24x7 analyst support is extended to our clients should the need be.
- 1. Executive Summary
- 1.1. Market Overview
- 1.2. Market Analysis
- 1.3. FMI Analysis and Recommendations
- 1.4. Wheel of Fortune
- 2. Market Introduction
- 2.1. Market Definition
- 2.2. Market Taxonomy
- 3. Orthobiologics Market Viewpoint
- 3.1. Macro-Economic Factors
- 3.2. Opportunity Analysis
- 3.3. Regulatory scenario
- 3.4. Porter’s Five Force Analysis
- 3.5. PESTLE Analysis
- 4. North America Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027
- 4.1. Introduction
- 4.2. Regional Market Dynamics
- 4.2.1. Drivers
- 4.2.2. Restraints
- 4.2.3. Trends
- 4.3. Historical Market Size (US$ Mn) By Country, 2012-2016
- 4.3.1. U.S.
- 4.3.2. Canada
- 4.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
- 4.4.1. U.S.
- 4.4.2. Canada
- 4.5. Historical Market Size (US$ Mn) By Product Type, 2012-2016
- 4.5.1. Bone Growth Stimulators
- 4.5.1.1. Non-Invasive Electrical BGS
- 4.5.1.2. Invasive Electrical BGS
- 4.5.1.3. Ultrasound BGS
- 4.5.2. VIscosupplements
- 4.5.2.1. One Injection VIscosupplements
- 4.5.2.2. Three Injection VIscosupplements
- 4.5.2.3. Five Injection VIscosupplements
- 4.5.3. Bone Graft Substitutes
- 4.5.3.1. Allografts
- 4.5.3.2. Synthetics
- 4.5.3.3. Xenografts
- 4.5.3.4. Bone Morphogenetic Protein
- 4.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
- 4.6.1. Bone Growth Stimulators
- 4.6.1.1. Non-Invasive Electrical BGS
- 4.6.1.2. Invasive Electrical BGS
- 4.6.1.3. Ultrasound BGS
- 4.6.2. VIscosupplements
- 4.6.2.1. One Injection VIscosupplements
- 4.6.2.2. Three Injection VIscosupplements
- 4.6.2.3. Five Injection VIscosupplements
- 4.6.3. Bone Graft Substitutes
- 4.6.3.1. Allografts
- 4.6.3.2. Synthetics
- 4.6.3.3. Xenografts
- 4.6.3.4. Bone Morphogenetic Protein
- 4.7. Historical Market Size (US$ Mn) By End User, 2012-2016
- 4.7.1. Hospitals
- 4.7.2. Ambulatory Surgical Centers
- 4.7.3. Orthopedic Clinics
- 4.8. Market Size (US$ Mn) Forecast By End User, 2017-2027
- 4.8.1. Hospitals
- 4.8.2. Ambulatory Surgical Centers
- 4.8.3. Orthopedic Clinics
- 4.9. Drivers and Restraints: Impact Analysis
- 4.10. Market Attractiveness Analysis
- 4.10.1. By Country
- 4.10.2. By Product Type
- 4.10.3. By End User
- 4.11. Key Representative Market Participants
- 4.12. Key Participants Market Presence (Intensity Map)
- 5. Latin America Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027
- 5.1. Introduction
- 5.2. Regional Market Dynamics
- 5.2.1. Drivers
- 5.2.2. Restraints
- 5.2.3. Trends
- 5.3. Historical Market Size (US$ Mn) By Country, 2012-2016
- 5.3.1. Brazil
- 5.3.2. Mexico
- 5.3.3. Argentina
- 5.3.4. Rest of Latin America
- 5.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
- 5.4.1. Brazil
- 5.4.2. Mexico
- 5.4.3. Argentina
- 5.4.4. Rest of Latin America
- 5.5. Historical Market Size (US$ Mn) By Product Type, 2012-2016
- 5.5.1. Bone Growth Stimulators
- 5.5.1.1. Non-Invasive Electrical BGS
- 5.5.1.2. Invasive Electrical BGS
- 5.5.1.3. Ultrasound BGS
- 5.5.2. VIscosupplements
- 5.5.2.1. One Injection VIscosupplements
- 5.5.2.2. Three Injection VIscosupplements
- 5.5.2.3. Five Injection VIscosupplements
- 5.5.3. Bone Graft Substitutes
- 5.5.3.1. Allografts
- 5.5.3.2. Synthetics
- 5.5.3.3. Xenografts
- 5.5.3.4. Bone Morphogenetic Protein
- 5.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
- 5.6.1. Bone Growth Stimulators
- 5.6.1.1. Non-Invasive Electrical BGS
- 5.6.1.2. Invasive Electrical BGS
- 5.6.1.3. Ultrasound BGS
- 5.6.2. VIscosupplements
- 5.6.2.1. One Injection VIscosupplements
- 5.6.2.2. Three Injection VIscosupplements
- 5.6.2.3. Five Injection VIscosupplements
- 5.6.3. Bone Graft Substitutes
- 5.6.3.1. Allografts
- 5.6.3.2. Synthetics
- 5.6.3.3. Xenografts
- 5.6.3.4. Bone Morphogenetic Protein
- 5.7. Historical Market Size (US$ Mn) By End User, 2012-2016
- 5.7.1. Hospitals
- 5.7.2. Ambulatory Surgical Centers
- 5.7.3. Orthopedic Clinics
- 5.8. Market Size (US$ Mn) Forecast By End User, 2017-2027
- 5.8.1. Hospitals
- 5.8.2. Ambulatory Surgical Centers
- 5.8.3. Orthopedic Clinics
- 5.9. Drivers and Restraints: Impact Analysis
- 5.10. Market Attractiveness Analysis
- 5.10.1. By Country
- 5.10.2. By Product Type
- 5.10.3. By End User
- 5.11. Key Representative Market Participants
- 5.12. Key Participants Market Presence (Intensity Map)
- 6. Western Europe Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027
- 6.1. Introduction
- 6.2. Regional Market Dynamics
- 6.2.1. Drivers
- 6.2.2. Restraints
- 6.2.3. Trends
- 6.3. Historical Market Size (US$ Mn) By Country, 2012-2016
- 6.3.1. Germany
- 6.3.2. United Kingdom
- 6.3.3. France
- 6.3.4. Italy
- 6.3.5. Spain
- 6.3.6. Benelux
- 6.3.7. Nordic Region
- 6.3.8. Rest of Western Europe
- 6.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
- 6.4.1. Germany
- 6.4.2. United Kingdom
- 6.4.3. France
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Benelux
- 6.4.7. Nordic Region
- 6.4.8. Rest of Western Europe
- 6.5. Historical Market Size (US$ Mn) By Product Type, 2012-2016
- 6.5.1. Bone Growth Stimulators
- 6.5.1.1. Non-Invasive Electrical BGS
- 6.5.1.2. Invasive Electrical BGS
- 6.5.1.3. Ultrasound BGS
- 6.5.2. VIscosupplements
- 6.5.2.1. One Injection VIscosupplements
- 6.5.2.2. Three Injection VIscosupplements
- 6.5.2.3. Five Injection VIscosupplements
- 6.5.3. Bone Graft Substitutes
- 6.5.3.1. Allografts
- 6.5.3.2. Synthetics
- 6.5.3.3. Xenografts
- 6.5.3.4. Bone Morphogenetic Protein
- 6.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
- 6.6.1. Bone Growth Stimulators
- 6.6.1.1. Non-Invasive Electrical BGS
- 6.6.1.2. Invasive Electrical BGS
- 6.6.1.3. Ultrasound BGS
- 6.6.2. VIscosupplements
- 6.6.2.1. One Injection VIscosupplements
- 6.6.2.2. Three Injection VIscosupplements
- 6.6.2.3. Five Injection VIscosupplements
- 6.6.3. Bone Graft Substitutes
- 6.6.3.1. Allografts
- 6.6.3.2. Synthetics
- 6.6.3.3. Xenografts
- 6.6.3.4. Bone Morphogenetic Protein
- 6.7. Historical Market Size (US$ Mn) By End User, 2012-2016
- 6.7.1. Hospitals
- 6.7.2. Ambulatory Surgical Centers
- 6.7.3. Orthopedic Clinics
- 6.8. Market Size (US$ Mn) Forecast By End User, 2017-2027
- 6.8.1. Hospitals
- 6.8.2. Ambulatory Surgical Centers
- 6.8.3. Orthopedic Clinics
- 6.9. Drivers and Restraints: Impact Analysis
- 6.10. Market Attractiveness Analysis
- 6.10.1. By Country
- 6.10.2. By Product Type
- 6.10.3. By End User
- 6.11. Key Representative Market Participants
- 6.12. Key Participants Market Presence (Intensity Map)
- 7. Eastern Europe Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027
- 7.1. Introduction
- 7.2. Regional Market Dynamics
- 7.2.1. Drivers
- 7.2.2. Restraints
- 7.2.3. Trends
- 7.3. Historical Market Size (US$ Mn) By Country, 2012-2016
- 7.3.1. Russia
- 7.3.2. Poland
- 7.3.3. Rest of Eastern Europe
- 7.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
- 7.4.1. Russia
- 7.4.2. Poland
- 7.4.3. Rest of Eastern Europe
- 7.5. Historical Market Size (US$ Mn) By Product Type, 2012-2016
- 7.5.1. Bone Growth Stimulators
- 7.5.1.1. Non-Invasive Electrical BGS
- 7.5.1.2. Invasive Electrical BGS
- 7.5.1.3. Ultrasound BGS
- 7.5.2. VIscosupplements
- 7.5.2.1. One Injection VIscosupplements
- 7.5.2.2. Three Injection VIscosupplements
- 7.5.2.3. Five Injection VIscosupplements
- 7.5.3. Bone Graft Substitutes
- 7.5.3.1. Allografts
- 7.5.3.2. Synthetics
- 7.5.3.3. Xenografts
- 7.5.3.4. Bone Morphogenetic Protein
- 7.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
- 7.6.1. Bone Growth Stimulators
- 7.6.1.1. Non-Invasive Electrical BGS
- 7.6.1.2. Invasive Electrical BGS
- 7.6.1.3. Ultrasound BGS
- 7.6.2. VIscosupplements
- 7.6.2.1. One Injection VIscosupplements
- 7.6.2.2. Three Injection VIscosupplements
- 7.6.2.3. Five Injection VIscosupplements
- 7.6.3. Bone Graft Substitutes
- 7.6.3.1. Allografts
- 7.6.3.2. Synthetics
- 7.6.3.3. Xenografts
- 7.6.3.4. Bone Morphogenetic Protein
- 7.7. Historical Market Size (US$ Mn) By End User, 2012-2016
- 7.7.1. Hospitals
- 7.7.2. Ambulatory Surgical Centers
- 7.7.3. Orthopedic Clinics
- 7.8. Market Size (US$ Mn) Forecast By End User, 2017-2027
- 7.8.1. Hospitals
- 7.8.2. Ambulatory Surgical Centers
- 7.8.3. Orthopedic Clinics
- 7.9. Drivers and Restraints: Impact Analysis
- 7.10. Market Attractiveness Analysis
- 7.10.1. By Country
- 7.10.2. By Product Type
- 7.10.3. By End User
- 7.11. Key Representative Market Participants
- 7.12. Key Participants Market Presence (Intensity Map)
- 8. Asia Pacific excluding Japan Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027
- 8.1. Introduction
- 8.2. Regional Market Dynamics
- 8.2.1. Drivers
- 8.2.2. Restraints
- 8.2.3. Trends
- 8.3. Historical Market Size (US$ Mn) By Country, 2012-2016
- 8.3.1. China
- 8.3.2. India
- 8.3.3. Australia and New Zealand
- 8.3.4. ASEAN
- 8.3.5. Rest of APEJ
- 8.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
- 8.4.1. China
- 8.4.2. India
- 8.4.3. Australia and New Zealand
- 8.4.4. ASEAN
- 8.4.5. Rest of APEJ
- 8.5. Historical Market Size (US$ Mn) By Product Type, 2012-2016
- 8.5.1. Bone Growth Stimulators
- 8.5.1.1. Non-Invasive Electrical BGS
- 8.5.1.2. Invasive Electrical BGS
- 8.5.1.3. Ultrasound BGS
- 8.5.2. VIscosupplements
- 8.5.2.1. One Injection VIscosupplements
- 8.5.2.2. Three Injection VIscosupplements
- 8.5.2.3. Five Injection VIscosupplements
- 8.5.3. Bone Graft Substitutes
- 8.5.3.1. Allografts
- 8.5.3.2. Synthetics
- 8.5.3.3. Xenografts
- 8.5.3.4. Bone Morphogenetic Protein
- 8.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
- 8.6.1. Bone Growth Stimulators
- 8.6.1.1. Non-Invasive Electrical BGS
- 8.6.1.2. Invasive Electrical BGS
- 8.6.1.3. Ultrasound BGS
- 8.6.2. VIscosupplements
- 8.6.2.1. One Injection VIscosupplements
- 8.6.2.2. Three Injection VIscosupplements
- 8.6.2.3. Five Injection VIscosupplements
- 8.6.3. Bone Graft Substitutes
- 8.6.3.1. Allografts
- 8.6.3.2. Synthetics
- 8.6.3.3. Xenografts
- 8.6.3.4. Bone Morphogenetic Protein
- 8.7. Historical Market Size (US$ Mn) By End User, 2012-2016
- 8.7.1. Hospitals
- 8.7.2. Ambulatory Surgical Centers
- 8.7.3. Orthopedic Clinics
- 8.8. Market Size (US$ Mn) Forecast By End User, 2017-2027
- 8.8.1. Hospitals
- 8.8.2. Ambulatory Surgical Centers
- 8.8.3. Orthopedic Clinics
- 8.9. Drivers and Restraints: Impact Analysis
- 8.10. Market Attractiveness Analysis
- 8.10.1. By Country
- 8.10.2. By Product Type
- 8.10.3. By End User
- 8.11. Key Representative Market Participants
- 8.12. Key Participants Market Presence (Intensity Map)
- 9. Japan Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027
- 9.1. Introduction
- 9.2. Regional Market Dynamics
- 9.2.1. Drivers
- 9.2.2. Restraints
- 9.2.3. Trends
- 9.3. Historical Market Size (US$ Mn) By Product Type, 2012-2016
- 9.3.1. Bone Growth Stimulators
- 9.3.1.1. Non-Invasive Electrical BGS
- 9.3.1.2. Invasive Electrical BGS
- 9.3.1.3. Ultrasound BGS
- 9.3.2. VIscosupplements
- 9.3.2.1. One Injection VIscosupplements
- 9.3.2.2. Three Injection VIscosupplements
- 9.3.2.3. Five Injection VIscosupplements
- 9.3.3. Bone Graft Substitutes
- 9.3.3.1. Allografts
- 9.3.3.2. Synthetics
- 9.3.3.3. Xenografts
- 9.3.3.4. Bone Morphogenetic Protein
- 9.4. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
- 9.4.1. Bone Growth Stimulators
- 9.4.1.1. Non-Invasive Electrical BGS
- 9.4.1.2. Invasive Electrical BGS
- 9.4.1.3. Ultrasound BGS
- 9.4.2. VIscosupplements
- 9.4.2.1. One Injection VIscosupplements
- 9.4.2.2. Three Injection VIscosupplements
- 9.4.2.3. Five Injection VIscosupplements
- 9.4.3. Bone Graft Substitutes
- 9.4.3.1. Allografts
- 9.4.3.2. Synthetics
- 9.4.3.3. Xenografts
- 9.4.3.4. Bone Morphogenetic Protein
- 9.5. Historical Market Size (US$ Mn) By End User, 2012-2016
- 9.5.1. Hospitals
- 9.5.2. Ambulatory Surgical Centers
- 9.5.3. Orthopedic Clinics
- 9.6. Market Size (US$ Mn) Forecast By End User, 2017-2027
- 9.6.1. Hospitals
- 9.6.2. Ambulatory Surgical Centers
- 9.6.3. Orthopedic Clinics
- 9.7. Drivers and Restraints: Impact Analysis
- 9.8. Market Attractiveness Analysis
- 9.8.1. By Product Type
- 9.8.2. By End User
- 9.9. Key Representative Market Participants
- 9.10. Key Participants Market Presence (Intensity Map)
- 10. Middle East & Africa Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027
- 10.1. Introduction
- 10.2. Regional Market Dynamics
- 10.2.1. Drivers
- 10.2.2. Restraints
- 10.2.3. Trends
- 10.3. Historical Market Size (US$ Mn) By Country, 2012-2016
- 10.3.1. GCC Countries
- 10.3.2. South Africa
- 10.3.3. Rest of MEA
- 10.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
- 10.4.1. GCC Countries
- 10.4.2. South Africa
- 10.4.3. Rest of MEA
- 10.5. Historical Market Size (US$ Mn) By Product Type, 2012-2016
- 10.5.1. Bone Growth Stimulators
- 10.5.1.1. Non-Invasive Electrical BGS
- 10.5.1.2. Invasive Electrical BGS
- 10.5.1.3. Ultrasound BGS
- 10.5.2. VIscosupplements
- 10.5.2.1. One Injection VIscosupplements
- 10.5.2.2. Three Injection VIscosupplements
- 10.5.2.3. Five Injection VIscosupplements
- 10.5.3. Bone Graft Substitutes
- 10.5.3.1. Allografts
- 10.5.3.2. Synthetics
- 10.5.3.3. Xenografts
- 10.5.3.4. Bone Morphogenetic Protein
- 10.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
- 10.6.1. Bone Growth Stimulators
- 10.6.1.1. Non-Invasive Electrical BGS
- 10.6.1.2. Invasive Electrical BGS
- 10.6.1.3. Ultrasound BGS
- 10.6.2. VIscosupplements
- 10.6.2.1. One Injection VIscosupplements
- 10.6.2.2. Three Injection VIscosupplements
- 10.6.2.3. Five Injection VIscosupplements
- 10.6.3. Bone Graft Substitutes
- 10.6.3.1. Allografts
- 10.6.3.2. Synthetics
- 10.6.3.3. Xenografts
- 10.6.3.4. Bone Morphogenetic Protein
- 10.7. Historical Market Size (US$ Mn) By End User, 2012-2016
- 10.7.1. Hospitals
- 10.7.2. Ambulatory Surgical Centers
- 10.7.3. Orthopedic Clinics
- 10.8. Market Size (US$ Mn) Forecast By End User, 2017-2027
- 10.8.1. Hospitals
- 10.8.2. Ambulatory Surgical Centers
- 10.8.3. Orthopedic Clinics
- 10.9. Drivers and Restraints: Impact Analysis
- 10.10. Market Attractiveness Analysis
- 10.10.1. By Country
- 10.10.2. By Product Type
- 10.10.3. By End User
- 10.11. Key Representative Market Participants
- 10.12. Key Participants Market Presence (Intensity Map)
- 11. Forecast Factors: Relevance and Impact
- 12. Forecast Assumptions
- 13. Competition Landscape
- 13.1. Market Structure
- 13.2. Market Share Analysis
- 13.3. Competition Dashboard
- 13.4. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
- 13.4.1. Medtronic plc
- 13.4.2. NuVasive, Inc.
- 13.4.3. Stryker Corporation
- 13.4.4. Zimmer Biomet Holdings
- 13.4.5. Orthofix International N.V.
- 13.4.6. Anika Therapeutics, Inc.
- 13.4.7. DePuy Synthes (Johnson & Johnson)
- 13.4.8. Bioventus
- 13.4.9. Arthrex, Inc.
- 13.4.10. SeaSpine Holdings Corporation
- 13.4.11. Sanofi-Aventis (Sanofi SA)
- 13.4.12. Djo Global, Inc.
- 13.4.13. Seikagaku Corporation
- 13.4.14. RTI Surgical, Inc.
- 13.4.15. Heraeus Holding GmbH
- 13.4.16. Fidia Pharma USA Inc.
- 13.4.17. TRB Chemedica International SA
- 13.4.18. Allosource
- 13.4.19. Musculoskeletal Transplant Foundation, Inc.
- 13.4.20. Ito Co., Ltd.
- 14. Global Orthobiologics Market Analysis and Forecast, By Region
- 14.1. Introduction
- 14.2. Historical Market Size (US$ Mn) By Region, 2012-2016
- 14.2.1. North America
- 14.2.2. Latin America
- 14.2.3. Western Europe
- 14.2.4. Eastern Europe
- 14.2.5. Asia Pacific Excl. Japan (APEJ)
- 14.2.6. Japan
- 14.2.7. Middle East and Africa (MEA)
- 14.3. Market Size (US$ Mn) Forecast By Region, 2017-2027
- 14.3.1. North America
- 14.3.2. Latin America
- 14.3.3. Western Europe
- 14.3.4. Eastern Europe
- 14.3.5. Asia Pacific Excl. Japan (APEJ)
- 14.3.6. Japan
- 14.3.7. Middle East and Africa (MEA)
- 14.4. Market Attractiveness Analysis By Region
- 15. Global Orthobiologics Market Analysis and Forecast, By Product Type
- 15.1. Introduction
- 15.2. Historical Market Size (US$ Mn) By Product Type, 2012-2016
- 15.2.1. Bone Growth Stimulators
- 15.2.1.1. Non-Invasive Electrical BGS
- 15.2.1.2. Invasive Electrical BGS
- 15.2.1.3. Ultrasound BGS
- 15.2.2. VIscosupplements
- 15.2.2.1. One Injection VIscosupplements
- 15.2.2.2. Three Injection VIscosupplements
- 15.2.2.3. Five Injection VIscosupplements
- 15.2.3. Bone Graft Substitutes
- 15.2.3.1. Allografts
- 15.2.3.2. Synthetics
- 15.2.3.3. Xenografts
- 15.2.3.4. Bone Morphogenetic Protein
- 15.3. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
- 15.3.1. Bone Growth Stimulators
- 15.3.1.1. Non-Invasive Electrical BGS
- 15.3.1.2. Invasive Electrical BGS
- 15.3.1.3. Ultrasound BGS
- 15.3.2. VIscosupplements
- 15.3.2.1. One Injection VIscosupplements
- 15.3.2.2. Three Injection VIscosupplements
- 15.3.2.3. Five Injection VIscosupplements
- 15.3.3. Bone Graft Substitutes
- 15.3.3.1. Allografts
- 15.3.3.2. Synthetics
- 15.3.3.3. Xenografts
- 15.3.3.4. Bone Morphogenetic Protein
- 15.4. Market Attractiveness Analysis By Product Type
- 16. Global Orthobiologics Market Analysis and Forecast, By End User
- 16.1. Introduction
- 16.2. Historical Market Size (US$ Mn) By End User, 2012-2016
- 16.2.1. Hospital
- 16.2.2. Ambulatory Surgical Centers
- 16.2.3. Orthopedic Clinics
- 16.3. Market Size (US$ Mn) Forecast By End User, 2017-2027
- 16.3.1. Hospital Pharmacies
- 16.3.2. Retail Pharmacies
- 16.3.3. Online Pharmacies
- 16.4. Market Attractiveness Analysis By End User
- 17. Global Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027
- 17.1. Market Size and Y-o-Y Growth
- 17.2. Absolute $ Opportunity
- 18. Assumptions and Acronyms Used
- 19. Research Methodology
- List of Tables
- Table 01: North America Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
- Table 02: North America Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
- Table 03: North America Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
- Table 04: Latin America Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
- Table 05: Latin America Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
- Table 06: Latin America Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
- Table 07: Western Europe Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
- Table 08: Western Europe Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
- Table 09: Western Europe Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
- Table 10: Eastern Europe Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
- Table 11: Eastern Europe Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
- Table 12: Eastern Europe Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
- Table 13: APEJ Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
- Table 14: APEJ Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
- Table 15: APEJ Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
- Table 16: Japan Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
- Table 17: Japan Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
- Table 18: MEA Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
- Table 19: MEA Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
- Table 20: MEA Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
- Table 21: Global Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Region
- Table 22: Global Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
- Table 23: Global Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User